Skip to content

Application of Electrical Impedance Tomography in Evaluating Pulmonary Function Improvement after Prone Positioning Therapy in ARDS Patients

Application of Electrical Impedance Tomography in Evaluating Pulmonary Function Improvement after Prone Positioning Therapy in ARDS Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107713
Enrollment
Unknown
Registered
2025-08-18
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute respiratory distress syndrome

Interventions

90-degree high lateral position group:Place the patient in the 90-degree high lateral position.
30-degree low lateral position group:Place the patient in the 30-degree low lateral position.
Prone position group:Patients will be placed in the prone position, i.e., lying face down.
120-degree high lateral position group:Place the patient in the 120-degree high lateral position.

Sponsors

The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years. 2. Diagnosis of ARDS according to the Berlin Definition (2023 update). 3. Clinically evaluated as suitable for positional therapy by physicians. 4. Signed informed consent obtained from the patient or legal representative. 5. Absence of severe spinal deformities or musculoskeletal disorders that may compromise safe high lateral positioning. 6. No severe skin conditions (e.g., extensive open wounds or pressure ulcers) that may affect the feasibility of lateral positioning.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women. 2. Severe cardiac diseases (e.g., unstable arrhythmia or heart failure) that may worsen with positional changes. 3. Severe coagulation disorders with increased bleeding risk. 4. Known allergy to the EIT device or any of its components. 5. Severe psychiatric disorders impairing study compliance. 6. Current participation in experimental therapies that may affect pulmonary function. 7. Severe active infections requiring special isolation measures. 8. Anticipated need for emergency surgery or life-threatening complications within 24 hours.

Design outcomes

Primary

MeasureTime frame
A/P Ratio;Oxygenation index;

Secondary

MeasureTime frame
Ventilation-Perfusion Ratio;Global Inhomogeneity Index, GI;

Countries

China

Contacts

Public ContactSong Lijun

The Fourth Affiliated Hospital, Zhejiang University School of Medicine

809475182@qq.com+86 158 6925 2244

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026